Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3025497 | Seminars in Thoracic and Cardiovascular Surgery | 2010 | 9 Pages |
Abstract
The treatment of patients with early-stage non-small cell lung cancer and cardiopulmonary dysfunction has rapidly evolved during the past decade. Although fractionated radiotherapy has been the most frequently used alternative treatment, additional approaches, including limited resection with or without brachytherapy, stereotactic body radiotherapy, and radiofrequency ablation are increasingly used and have now been studied prospectively. This review will focus on the potential current role of fractionated radiotherapy for high-risk patients with particular consideration of altered fractionation schemes and recent advances in treatment related technology.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jeffrey A. MD,